Skip to main content
. 2017 Apr 21;8:15099. doi: 10.1038/ncomms15099

Figure 5. Percentage of MDS cells in various bone marrow stem and progenitor cell fractions.

Figure 5

From six MDS patients with sufficient material (UPN01, 03, 04, 05, 06 and 10), we sorted different bone marrow stem and progenitor cell fractions at various time points. Some minor differences in tumour burden are observed between the various fractions. BL, baseline; HSC, haematopoietic stem cell; CMP, common myeloid progenitor; GMP, granulocyte–macrophage progenitor; MEP, megakaryocyte–erythroid progenitor.